scispace - formally typeset
J

Jennifer Logue

Researcher at University of Washington

Publications -  121
Citations -  4126

Jennifer Logue is an academic researcher from University of Washington. The author has contributed to research in topics: Medicine & Antibody. The author has an hindex of 18, co-authored 79 publications receiving 2176 citations. Previous affiliations of Jennifer Logue include Glasgow Royal Infirmary & University of Glasgow.

Papers
More filters
Journal ArticleDOI

Sequelae in Adults at 6 Months After COVID-19 Infection.

TL;DR: In this paper, the authors reported persistent symptoms and a decline in health-related quality of life (HRQoL) after coronavirus disease 2019 (COVID-19) illness.
Journal ArticleDOI

Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology

TL;DR: The coexistence of type 2 diabetes mellitus and heart failure (HF), either with reduced (HFrEF) or preserved ejection fraction (HFpEF), is frequent and associated with a higher risk of HF hospitalization, all‐cause and cardiovascular (CV) mortality.
Journal ArticleDOI

Association between general and central adiposity in childhood, and change in these, with cardiovascular risk factors in adolescence: prospective cohort study

TL;DR: Measurements of waist circumference or directly assessed fat mass in childhood do not seem to be associated with cardiovascular risk factors in adolescence any more strongly than BMI, and BMI, waist circumference, and fat mass were all strongly correlated with each other.
Journal ArticleDOI

Do men develop type 2 diabetes at lower body mass indices than women

TL;DR: Men are diagnosed with type 2 diabetes at lower BMI than women across the age range, and this observation may help explain why type-2 diabetes is more common among middle-aged men in populations of European extraction.
Journal ArticleDOI

Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

TL;DR: In this article, the authors quantified how levels of these antibodies change in the months after SARS-CoV-2 infection by examining longitudinal samples collected approximately 30-152 days after symptom onset from a prospective cohort of 32 recovered individuals with asymptomatic, mild, or moderate-severe disease.